Neuberger Berman Group LLC Neogenomics Inc Transaction History

Neuberger Berman Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $1.54 Million - $4.46 Million	-126,479 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $25,550 - $40,634	-838 Reduced 0.66%	126,479 $4.25 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $131,270 - $165,490	3,151 Added 2.54%	127,317 $6.01 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $611,480 - $863,119	-16,698 Reduced 11.85%	124,166 $5.59 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $1.04 Million - $1.5 Million	25,114 Added 21.7%	140,864 $6.78 Million
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $833,448 - $1.3 Million	23,100 Added 24.93%	115,750 $6.22 Million
Q3 2020 Nov 12, 2020	BUY	$33.26 - $40.48 $11,641 - $14,167	350 Added 0.38%	92,650 $3.42 Million
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $1.22 Million - $1.56 Million	50,300 Added 119.76%	92,300 $2.85 Million
Q3 2019 Nov 13, 2019	BUY	$19.12 - $26.24 $803,040 - $1.1 Million	42,000 New	42,000 $803,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.